DNER and metabolic dysfunction-associated steatohepatitis: Interestingly, the specific genes and pathways affected by BET inhibition have been found to be highly cell type specific33 indicating that an accurate evaluation of the potential therapeutic impact of BET inhibition for NASH requires examining its effects in liver tissue.